By ANDREW POLLACK
The decision clears the way for Amarin to promote patient use of its drug Vascepa in a way that the F.D.A. declined to approve.
Published: August 8, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1MfHm15
from WordPress http://ift.tt/1KW5xkH
via Hadi Aboukhater
No comments:
Post a Comment